Male sexual medicine has continued to evolve and several publications related to premature ejaculation, lower urinary tract symptoms, Peyronie's disease and testosterone replacement therapy have provided new insights in these fields. Our understanding has been revolutionized by these studies and clinical management in male sexual dysfunction has improved.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
McMahon, C. G. et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J. Sex. Med. 5, 1590–1606 (2008).
Serefoglu, E. C. et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J. Sex. Med. 11, 1423–1441 (2014).
Roehrborn, C. G. et al. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J. Urol. 179, 616–621 (2008).
Glina, S. et al. Sexual Function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-Month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride. J. Sex. Med. http://dx.doi.org/10.1111/jsm.12714 (2014).
Levine, L. A. et al. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with peyronie's disease: a phase 3 open-label study. J. Sex. Med. http://dx.doi.org/10.1111/jsm.12731 (2014).
Vigen, R. et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 310, 1829–1836 (2013).
Carson, C. C. 3rd & Rosano, G. Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data. J. Sex. Med. 9, 54–67 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Saitz, T., Serefoglu, E. Men enjoy a year of significant progress. Nat Rev Urol 12, 73–74 (2015). https://doi.org/10.1038/nrurol.2014.357
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2014.357
